$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-K Financial Statement

#000119312514354731 Filed on September 26, 2014

Income Statement

Concept	2014 Q2	2014	2013 Q2
Revenue	$21.60M	$116.5M	$25.45M
YoY Change	-15.11%	-2.98%	-4.46%
Cost Of Revenue	$4.270M	$3.288M	$4.280M
YoY Change	-0.23%	-44.46%	-12.83%
Gross Profit	-$880.0K	$113.2M	$21.25M
YoY Change	-104.14%	-0.83%	-2.16%
Gross Profit Margin	-4.07%	97.18%	83.51%
Selling, General & Admin	-$1.400M	$41.43M	$17.47M
YoY Change	-108.01%	-42.22%	1.45%
% of Gross Profit		36.59%	82.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.660M	$3.662M	$4.050M
YoY Change	-9.63%	-9.54%	297.06%
% of Gross Profit		3.23%	19.06%
Operating Expenses	-$2.430M	$50.62M	$18.61M
YoY Change	-113.06%	-41.21%	16.68%
Operating Profit	$1.550M	$1.042M	$2.640M
YoY Change	-41.29%	-156.14%	-54.25%
Interest Expense	-$230.0K	$944.0K	-$290.0K
YoY Change	-20.69%	-38.42%	-70.41%
% of Operating Profit	-14.84%	90.6%	-10.98%
Other Income/Expense, Net	-$1.040M	$3.911M	$90.00K
YoY Change	-1255.56%	-20.94%
Pretax Income	$1.260M	-$1.303M	$2.350M
YoY Change	-46.38%	-54.93%	-50.84%
Income Tax	$740.0K	$541.0K	$720.0K
% Of Pretax Income	58.73%		30.64%
Net Earnings	$1.350M	-$545.0K	$2.163M
YoY Change	-37.59%	-112.14%	-57.7%
Net Earnings / Revenue	6.25%	-0.47%	8.5%
Basic Earnings Per Share	$0.14	-$0.06	$0.23
Diluted Earnings Per Share	$0.14	-$0.06	$0.23
COMMON SHARES
Basic Shares Outstanding	9.443M shares	9.443M shares	9.443M shares
Diluted Shares Outstanding	9.476M shares	9.456M shares	9.443M shares

Balance Sheet

Concept	2014 Q2	2014	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.600M	$3.587M	$2.700M
YoY Change	33.33%	32.85%	28.57%
Cash & Equivalents	$3.587M	$3.587M	$2.497M
Short-Term Investments
Other Short-Term Assets	$8.500M	$8.581M	$7.500M
YoY Change	13.33%	14.41%	-33.04%
Inventory	$3.757M	$3.757M	$3.798M
Prepaid Expenses
Receivables	$2.786M	$9.850M	$0.00
Other Receivables	$0.00	$0.00	$1.700M
Total Short-Term Assets	$25.78M	$25.78M	$28.09M
YoY Change	-8.25%	-8.27%	-8.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.33M	$23.08M	$30.57M
YoY Change	-23.71%	-24.58%	1.64%
Goodwill	$461.0K		$461.0K
YoY Change	0.0%		0.0%
Intangibles	$2.979M		$3.175M
YoY Change	-6.17%		-4.37%
Long-Term Investments
YoY Change
Other Assets	$1.025M	$11.56M	$1.587M
YoY Change	-35.41%	102.72%	77.52%
Total Long-Term Assets	$38.07M	$38.07M	$39.91M
YoY Change	-4.61%	-4.58%	-17.8%
TOTAL ASSETS
Total Short-Term Assets	$25.78M	$25.78M	$28.09M
Total Long-Term Assets	$38.07M	$38.07M	$39.91M
Total Assets	$63.85M	$63.85M	$68.00M
YoY Change	-6.11%	-6.11%	-14.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.530M	$4.530M	$5.474M
YoY Change	-17.25%	-17.64%	-21.06%
Accrued Expenses	$6.500M	$6.500M	$5.500M
YoY Change	18.18%	18.18%	-23.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$561.0K	$561.0K	$9.542M
YoY Change	-94.12%	-94.09%	2.05%
Total Short-Term Liabilities	$16.51M	$16.51M	$22.25M
YoY Change	-25.8%	-25.65%	-30.07%
LONG-TERM LIABILITIES
Long-Term Debt	$11.95M	$11.95M	$8.728M
YoY Change	36.89%	37.33%	-36.48%
Other Long-Term Liabilities	$807.0K	$2.075M	$825.0K
YoY Change	-2.18%	-37.12%	-9.04%
Total Long-Term Liabilities	$14.02M	$14.02M	$12.01M
YoY Change	16.72%	16.86%	-33.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.51M	$16.51M	$22.25M
Total Long-Term Liabilities	$14.02M	$14.02M	$12.01M
Total Liabilities	$30.53M	$30.53M	$34.26M
YoY Change	-10.89%	-10.99%	-31.32%
SHAREHOLDERS EQUITY
Retained Earnings	$15.49M		$16.03M
YoY Change	-3.4%		38.88%
Common Stock	$18.17M		$4.722M
YoY Change	284.71%		-0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.30M	$33.32M	$33.74M
YoY Change
Total Liabilities & Shareholders Equity	$63.85M	$63.85M	$68.00M
YoY Change	-6.11%	-6.11%	-14.11%

Cashflow Statement

Concept	2014 Q2	2014	2013 Q2
OPERATING ACTIVITIES
Net Income	$1.350M	-$545.0K	$2.163M
YoY Change	-37.59%	-112.14%	-57.7%
Depreciation, Depletion And Amortization	$3.660M	$3.662M	$4.050M
YoY Change	-9.63%	-9.54%	297.06%
Cash From Operating Activities	$570.0K	$3.892M	$2.330M
YoY Change	-75.54%	-293.06%	-37.7%
INVESTING ACTIVITIES
Capital Expenditures	-$510.0K	$1.483M	-$2.820M
YoY Change	-81.91%	-69.05%	213.33%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$160.0K	$800.0K
YoY Change	-100.0%	-100.87%	-310.53%
Cash From Investing Activities	-$510.0K	-$1.883M	-$2.020M
YoY Change	-74.75%	-114.03%	59.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net		$795.0K
YoY Change		-95.43%
Cash From Financing Activities	-300.0K	-919.0K	-370.0K
YoY Change	-18.92%	-91.62%	-71.09%
NET CHANGE
Cash From Operating Activities	570.0K	3.892M	2.330M
Cash From Investing Activities	-510.0K	-1.883M	-2.020M
Cash From Financing Activities	-300.0K	-919.0K	-370.0K
Net Change In Cash	-240.0K	1.090M	-60.00K
YoY Change	300.0%	147.73%	-105.04%
FREE CASH FLOW
Cash From Operating Activities	$570.0K	$3.892M	$2.330M
Capital Expenditures	-$510.0K	$1.483M	-$2.820M
Free Cash Flow	$1.080M	$2.409M	$5.150M
YoY Change	-79.03%	-135.39%	10.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	ssy	Minimum Outstanding Stock Percentage Required To Trigger Poison Pill MinimumOutstandingStockPercentageRequiredToTriggerPoisonPill	0.20	pure
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9443408	shares
CY2013Q4	dei	Entity Public Float EntityPublicFloat	2497012
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.80
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	174249	shares
CY2011Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26068000
CY2011Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-278000
CY2011Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	37000
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7250000
CY2011Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-278000
CY2011Q3	us-gaap	Share Price SharePrice	1.90
CY2011Q3	ssy	Pre Payment On Credit Facility Term Loan PrePaymentOnCreditFacilityTermLoan	8000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.62
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	220498	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.75
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400499	shares
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29291000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-497000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19000
CY2012Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1536000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9121000
CY2012Q2	us-gaap	Assets Net AssetsNet	79172000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2057000
CY2012Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	985000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-497000
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2013Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404163	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.18
CY2012	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	133000
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22246000
CY2013Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	90000
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0
CY2013Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	18270000
CY2013Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12014000
CY2013Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	216000
CY2013Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	617499	shares
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33743000
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1417000
CY2013Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2151000
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34266000
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-406000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5474000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16031000
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	9542000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	825000
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8728000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68003000
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13396000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1136000
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	229000
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4121000
CY2013Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1353000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7761000
CY2013Q2	us-gaap	Assets Net AssetsNet	68003000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2497000
CY2013Q2	us-gaap	Goodwill Goodwill	461000
CY2013Q2	us-gaap	Land Land	1992000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30574000
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	12356000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2013Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3762000
CY2013Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10272000
CY2013Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-616000
CY2013Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	737000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3505000
CY2013Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	29452000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	313000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	564000
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	11000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	808000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16481000
CY2014Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	74000
CY2014Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	41000
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	73000
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	17351000
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4113000
CY2013Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	20117000
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2013Q2	us-gaap	Escrow Deposit EscrowDeposit	160000
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64840000
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2013Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3279000
CY2013Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	9336000
CY2013Q2	us-gaap	Assets Assets	68003000
CY2013Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8121000
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4008000
CY2013Q2	us-gaap	Inventory Net InventoryNet	3798000
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-406000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2571000
CY2013Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	-652000
CY2013Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1769000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3175000
CY2013Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	33396000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1587000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	28093000
CY2013Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	36000
CY2013Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1868000
CY2013Q2	ssy	Due To Third Party Payors DueToThirdPartyPayors	556000
CY2013Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	2546000
CY2013Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	2461000
CY2013Q2	ssy	Deferred Tax Assets Deferred Gain On Incentive Reimbursements DeferredTaxAssetsDeferredGainOnIncentiveReimbursements	461000
CY2013Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	36000
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2014Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2014Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	24.74	acre
CY2014Q2	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	1.00	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	448998	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.97
CY2014Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2014Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.50
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548999	shares
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33318000
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2314000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	7939000
CY2014Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	66000
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2577000
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36702000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	620000
CY2014Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	5378000
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13444000
CY2014Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	62000
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	807000
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3417000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5378000
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	29000
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	700000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1839000
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11973000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63847000
CY2014Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	847000
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14048000
CY2014Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	59000
CY2014Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	115000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4186000
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1549000
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	767000
CY2014Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1366000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4530000
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15486000
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	281000
CY2014Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	64000
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6903000
CY2014Q2	us-gaap	Assets Net AssetsNet	63847000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3587000
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	16000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	145000
CY2014Q2	us-gaap	Goodwill Goodwill	461000
CY2014Q2	us-gaap	Land Land	1992000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28719000
CY2014Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9850000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2014Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3223000
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9987000
CY2014Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-549000
CY2014Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	816000
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2565000
CY2014Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	29826000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1031000
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4432000
CY2014Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	16753000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	218000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	467000
CY2014Q2	us-gaap	Escrow Deposit EscrowDeposit	0
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	145000
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	65421000
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4288000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	306000
CY2014Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	9353000
CY2014Q2	us-gaap	Assets Assets	63847000
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7410000
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2978000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	145000
CY2014Q2	us-gaap	Inventory Net InventoryNet	4009000
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2786000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-334000
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2341000
CY2014Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	-535000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	145000
CY2014Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3031000
CY2014Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	33603000
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1429000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	25775000
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	145000
CY2014Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	-14000
CY2014Q2	ssy	Long Term Debt Contractual Commitments LongTermDebtContractualCommitments	6228000
CY2014Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1549000
CY2014Q2	ssy	Due To Third Party Payors DueToThirdPartyPayors	0
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Next Twelve Months LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths	981000
CY2014Q2	ssy	Reserve For Discontinued Operation ReserveForDiscontinuedOperation	0
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Five LongTermDebtContractualCommitmentsForInterestInYearFive	490000
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Three LongTermDebtContractualCommitmentsForInterestInYearThree	678000
CY2014Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	2099000
CY2014Q2	ssy	Plans Assets Invested In Cash And Short Term Investments PlansAssetsInvestedInCashAndShortTermInvestments	0.59	pure
CY2014Q2	ssy	Common Stock Shares Issued And Outstanding CommonStockSharesIssuedAndOutstanding	9443334	shares
CY2014Q2	ssy	Plan Expected To Pay In Pension Benefits Through Three Years PlanExpectedToPayInPensionBenefitsThroughThreeYears	337000
CY2014Q2	ssy	Plans Assets Invested In Equity Investments PlansAssetsInvestedInEquityInvestments	0.26	pure
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year After Five Year LongTermDebtContractualCommitmentsForInterestInYearAfterFiveYear	2771000
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Two LongTermDebtContractualCommitmentsForInterestInYearTwo	731000
CY2014Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	1268000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-1095000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4579000
CY2014Q2	ssy	Plans Assets Invested In Fixed Income Investments PlansAssetsInvestedInFixedIncomeInvestments	0.15	pure
CY2014Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Four LongTermDebtContractualCommitmentsForInterestInYearFour	577000
CY2014Q2	ssy	Deferred Tax Assets Deferred Gain On Incentive Reimbursements DeferredTaxAssetsDeferredGainOnIncentiveReimbursements	0
CY2014Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	-14000
CY2011Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000
CY2011Q3	ssy	Share Issued Under Private Placement ShareIssuedUnderPrivatePlacement	1329000	shares
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2016000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	43000	shares
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	11770000
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.00	pure
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	260000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.64
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.22
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.13
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9445000	shares
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.64
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	617000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9445000	shares
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-160000
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2116000
CY2013	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	10450000
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	17519000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	91000
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-873000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	6073000
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	108308000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	153000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-86000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2891000
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	263000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	218000
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	213000
CY2013	us-gaap	Revenues Revenues	120078000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4975000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	4488000
CY2013	us-gaap	Interest Paid InterestPaid	1752000
CY2013	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	9615000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86000
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1585000
CY2013	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-41000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2914000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4048000
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	18000
CY2013	us-gaap	Interest Expense InterestExpense	1796000
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1000
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	222000
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1571000
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	52660000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	597000
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	213000
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	13727000
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	145000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	440000
CY2013	us-gaap	Cost Of Services CostOfServices	7480000
CY2013	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	292000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-983000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1306000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13420000
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1918000
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22363000
CY2013	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1000
CY2013	us-gaap	Depreciation Depreciation	3903000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	0
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	29000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10964000
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	91000
CY2013	us-gaap	Other Expenses OtherExpenses	4947000
CY2013	us-gaap	Supplies Expense SuppliesExpense	9095000
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1529000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4220000
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2013	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	43000
CY2013	ssy	Funded Status Of Plans FundedStatusOfPlans	616000
CY2013	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	45000
CY2013	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	2944000
CY2013	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	-1135000
CY2013	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	91000
CY2013	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	652000
CY2013	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	0
CY2013	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.22
CY2013	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	166000
CY2013	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	0
CY2013	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	55000
CY2013	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	11770000
CY2013	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	159000
CY2013	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3794000
CY2013	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-476000
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-5931000
CY2013	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1004000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	86000
CY2013	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2013	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	68000
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4640000
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	106000
CY2013	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15400000
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12699000
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000
CY2013	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1032000
CY2013	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	9748000
CY2013	ssy	Net Operating Loss Carryforward Expiration Year NetOperatingLossCarryforwardExpirationYear	2023
CY2013	ssy	Guarantee Expenses GuaranteeExpenses	137000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2014	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2008-04-23
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2631	shares
CY2014	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2"><b>1.</b></font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2"><b>BUSINESS OPERATIONS</b></font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px" align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">SunLink Health Systems, Inc. through subsidiaries (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”), owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</font></p> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">•</font></td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">The Healthcare Facilities Segments is composed of three operational areas:</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Four community hospital subsidiaries in three states with a total of 232 licensed beds;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to, or in close proximity with a corresponding SunLink community hospital; and</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">A Clanton, Alabama healthcare facility which is currently vacant except for two offices rented to a physician and a testing lab.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">•</font></td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">The Specialty Pharmacy Segment is composed of four operational areas:</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Retail pharmacy products and services, all of which are conducted in rural markets;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Institutional pharmacy services;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Specialty pharmacy services; and</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: 'Times New Roman'" size="2">–</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Durable medical equipment.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <font size="1"> </font></p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px" align="justify"><font style="FONT-FAMILY: 'Times New Roman'" size="2">SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy operations since April 2008. Our Specialty Pharmacy Segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</font></p> </div>
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3892000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	89500	shares
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	11065000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.00	pure
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2014	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2013-01-01
CY2014	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> <b><i>Management Estimates</i></b>—The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</p> </div>
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2014	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.09
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.71
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.15
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M22D
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.71
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.09
CY2014	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Estimated useful lives of the assets, which range from 3 to 45 years
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.93	pure
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	298000	shares
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> <b><i>Concentrations of Credit Risk</i></b>—SunLink subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries’ facilities and are insured under third-party agreements. Although SunLink’s two Georgia facilities generated approximately 51%, 53%, and 51% of gross revenues for the years ended June 30, 2014, 2013 and 2012, respectively, because of the geographic diversity of SunLink’s facilities and nongovernmental third-party payors, Medicare and Medicaid accounts represent SunLink’s only significant concentrations of credit risk. For SunLink’s Healthcare Facilities Segment, Medicare net revenues were approximately 41%, 40%, and 37% of net revenues for the years ended June 30, 2014, 2013 and 2012, respectively. For SunLink’s Healthcare Facilities Segment, Medicaid was approximately 21%, 20%, and 22% of net revenues for the years ended June 30, 2014, 2013 and 2012, respectively. For SunLink’s Healthcare Facilities Segment, Medicare receivables were approximately 47% and 44% of receivables—net at June 30, 2014 and 2013, respectively, while Medicaid receivables were approximately 12% and 15% of receivables—net at June 30, 2014 and 2013, respectively.</p> </div>
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	919000
CY2014	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	160000
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1881000
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	72000
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2505000
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	846000
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	105430000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1487000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	211000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1303000
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-43000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-40000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-473000
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1296000
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2014	us-gaap	Revenues Revenues	116495000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1723000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-545000
CY2014	us-gaap	Interest Paid InterestPaid	1128000
CY2014	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	8822000
CY2014	us-gaap	Supplies Expense SuppliesExpense	8605000
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	72000
CY2014	us-gaap	Other Expenses OtherExpenses	3911000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48000
CY2014	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1391000
CY2014	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	0
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-236000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3662000
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	56000
CY2014	us-gaap	Interest Expense InterestExpense	1220000
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1842000
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	51096000
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	254000
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	12177000
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	144000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1090000
CY2014	us-gaap	Cost Of Services CostOfServices	7183000
CY2014	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	46000
CY2014	us-gaap	Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear	120000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-443000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1883000
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1775000
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22110000
CY2014	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	17000
CY2014	us-gaap	Depreciation Depreciation	3520000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	1000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	16000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-919000
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-137000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	324000
CY2014	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	108000
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	11065000
CY2014	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	1076000
CY2014	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1128000
CY2014	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	31000
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0
CY2014	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	689000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	48000
CY2014	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2014	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	59000
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	450000
CY2014	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	427000
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	14696000
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2014	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4000
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	229000
CY2014	ssy	Defined Contribution Plan Employer Matching Contribution DefinedContributionPlanEmployerMatchingContribution	120000
CY2014	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	3342000
CY2014	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	543000
CY2014	ssy	Number Of Stockholders To Whom Shares Issued NumberOfStockholdersToWhomSharesIssued	68	Stockholders
CY2014	ssy	Expected Return On Investment ExpectedReturnOnInvestment	0.04	pure
CY2014	ssy	Maximum Period Of Accounts Receivable Written Off MaximumPeriodOfAccountsReceivableWrittenOff	P120D
CY2014	ssy	Number Of Physicians Under Guarantee Agreements NumberOfPhysiciansUnderGuaranteeAgreements	1	Physician
CY2014	ssy	Guarantee Expenses GuaranteeExpenses	110000
CY2014	ssy	Stock Issued During Period Value Bonus Shares StockIssuedDuringPeriodValueBonusShares	100000
CY2014	ssy	Maximum Number Of Record Holders Under Odd Lot Tender Offer MaximumNumberOfRecordHoldersUnderOddLotTenderOffer	300	Stockholders
CY2014	ssy	Funded Status Of Plans FundedStatusOfPlans	549000
CY2014	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	0
CY2014	ssy	Stock Repurchased And Retired During Period Bonus Value StockRepurchasedAndRetiredDuringPeriodBonusValue	7000
CY2014	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	803000
CY2014	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	1135000
CY2014	ssy	Maximum Number Of Shares Held By Stockholders Under Tender Offer MaximumNumberOfSharesHeldByStockholdersUnderTenderOffer	99	shares
CY2014	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	72000
CY2014	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	535000
CY2014	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	0
CY2014	ssy	Loss Contingency Lawsuit Date LossContingencyLawsuitDate	2007-04-17
CY2014	ssy	Number Of Law Firms Related To Entities NumberOfLawFirmsRelatedToEntities	2	Law_Firm
CY2014	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	0.71
CY2014	ssy	Stock Repurchased And Retired During Period Aggregate Value StockRepurchasedAndRetiredDuringPeriodAggregateValue	195000
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.18
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	250000	shares
CY2014	ssy	Stock Repurchased And Retired During Period Fee And Expense Value StockRepurchasedAndRetiredDuringPeriodFeeAndExpenseValue	184000
CY2014	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	214000
CY2014	ssy	Number Of Stockholders NumberOfStockholders	480	Stockholders
CY2014	ssy	Financing Costs And Expenses FinancingCostsAndExpenses	2710000
CY2014	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	0
CY2014	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	44000
CY2014	ssy	Age Of Participants To Take Monthly Pension Benefits One AgeOfParticipantsToTakeMonthlyPensionBenefitsOne	P65Y
CY2012	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3082000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	23750	shares
CY2012	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.00	pure
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2012	us-gaap	Interest Expense InterestExpense	4377000
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	201000
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1328000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0134	pure
CY2012	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0650	pure
CY2012	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.00	pure
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.29
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.09
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.67
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9350000	shares
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.18
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.97
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.29
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.76	pure
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	411000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9350000	shares
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2342000
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1242000
CY2012	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13622000
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-219000
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3000000
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2757000
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	113216000
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	352000
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-204000
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2241000
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-20000
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	2156000
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	862000
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	4108000
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2012	us-gaap	Revenues Revenues	123269000
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1518000
CY2012	us-gaap	Net Income Loss NetIncomeLoss	1081000
CY2012	us-gaap	Interest Paid InterestPaid	4029000
CY2012	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	9566000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92000
CY2012	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1676000
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92000
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges	931000
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	203000
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4365000
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	39000
CY2012	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2012	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1351000
CY2012	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-219000
CY2012	ssy	Long Term Debt Issued As Payment In Kind For Interest Payable LongTermDebtIssuedAsPaymentInKindForInterestPayable	105000
CY2012	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	547000
CY2012	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	349000
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	52115000
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	632000
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	157000
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5193000
CY2012	us-gaap	Cost Of Services CostOfServices	7958000
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-909000
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-565000
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2014000
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2191000
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	26073000
CY2012	us-gaap	Depreciation Depreciation	4207000
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	316000
CY2012	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-73000
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	31000
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6261000
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-219000
CY2012	us-gaap	Other Expenses OtherExpenses	7294000
CY2012	us-gaap	Supplies Expense SuppliesExpense	8428000
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	1993000
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-768000
CY2012	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	10053000
CY2012	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	3411000
CY2012	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	931000
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1833000
CY2012	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-9000
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	80000
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2342000
CY2012	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	631000
CY2012	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1092000
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	92000
CY2012	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-33000
CY2012	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15661000
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4388000
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	18000
CY2012	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-33000
CY2012	ssy	Disposal Group Including Discontinued Operation Revenue Net Of Expenses DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses	34709000
CY2012	ssy	Guarantee Expenses GuaranteeExpenses	340000
CY2012	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	496000
CY2012	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	568000
CY2012	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	8348000
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	29319000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-186000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-197000
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	27718000
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-964000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-911000
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.17
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	25445000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	2163000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1629000
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9476000	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	25070000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	1350000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	707000
CY2011Q3	ssy	Common Shares Sought To Sell In Private Offering CommonSharesSoughtToSellInPrivateOffering	3800000	shares
CY2011Q3	ssy	Minimum Amount Through Private Placement Of Shares MinimumAmountThroughPrivatePlacementOfShares	2500000
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	25694000
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-1424000
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1622000
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	27850000
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	3935000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1395000
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	25578000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-1158000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1174000
CY2013Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9447000	shares
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9447000	shares
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	27064000
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	227000
CY2013Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-13000

Files In Submission

Name	View Source	Status
0001193125-14-354731-index-headers.html	Edgar Link	pending
0001193125-14-354731-index.html	Edgar Link	pending
0001193125-14-354731.txt	Edgar Link	pending
0001193125-14-354731-xbrl.zip	Edgar Link	pending
d737445d10k.htm	Edgar Link	pending
d737445dex1029.htm	Edgar Link	pending
d737445dex1030.htm	Edgar Link	pending
d737445dex211.htm	Edgar Link	pending
d737445dex231.htm	Edgar Link	pending
d737445dex311.htm	Edgar Link	pending
d737445dex312.htm	Edgar Link	pending
d737445dex321.htm	Edgar Link	pending
d737445dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g737445g04r77.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20140630.xml	Edgar Link	completed
ssy-20140630.xsd	Edgar Link	pending
ssy-20140630_cal.xml	Edgar Link	unprocessable
ssy-20140630_def.xml	Edgar Link	unprocessable
ssy-20140630_lab.xml	Edgar Link	unprocessable
ssy-20140630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2014 Q2 Form 10-K Financial Statement

#000119312514354731 Filed on September 26, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2014 Q2 Form 10-K Financial Statement

#000119312514354731 Filed on September 26, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy